Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 4
Submit an article Journal homepage
146
Views
4
CrossRef citations to date
0
Altmetric
Letter

Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature

Reza SetoodehDepartment of Hematopathology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USACorrespondence[email protected]
&
Ling ZhangDepartment of Hematopathology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
Pages 736-738 | Received 23 Jul 2011, Accepted 26 Sep 2011, Published online: 27 Apr 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kalman Filanovsky, Rinat Yacobi, Eliakim Vorst, Iris Barshack, Eva Ustaev, Edit Feldberg & Lev Shvidel. (2015) Second hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene. Leukemia & Lymphoma 56:3, pages 823-825.
Read now

Articles from other publishers (3)

Barbara Kiesewetter, Werner Dolak, Ingrid Simonitsch-Klupp, Marius E. Mayerhoefer & Markus Raderer. (2017) Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma. Hematological Oncology 35:2, pages 177-186.
Crossref
Katarzyna Wi?niewska-Pi?ty, Grzegorz Helbig, Krzysztof Wo?niczka, Joanna Dziaczkowska-Suszek & S?awomira Kyrcz-Krzemie?. (2014) Hairy cell leukemia and multiple myeloma: Two distinct entities or a single two-phase disease. Acta Haematologica Polonica 45:1, pages 86-88.
Crossref
. (2012) First reports of serious adverse drug reactions in recent weeks. Drugs & Therapy Perspectives 28:12, pages 18-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.